We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 183

CIPO-EPO PPH pilot programme set to begin in January 2015

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, European Union
  • -
  • December 10 2014

In another step towards building stronger bilateral relations and fast tracking the examination of counterpart patent applications, the Canadian

Listing patents against combination drugs in Canada ? Changes coming

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 1 2014

On Nov. 26, 2014, Industry Canada announced an important proposed change to the eligibility requirements for listing a patent against a drug in

Canada prepares for Patent Law Treaty

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 6 2014

The Canadian Patent Act (the "Patent Act") is undergoing amendment courtesy of Bill C-43, known as the Economic Action Plan 2014 Act, No. 2 tabled in

Le programme pilote d’ATDB entre l’OPIC et l’OEB débutera en janvier 2015

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, European Union
  • -
  • November 4 2014

Dans le cadre d’une nouvelle mesure visant à consolider les relations bilatérales et à accélérer le processus d’examen de demandes de brevets

Court of Appeal again interprets utility requirement in Celebrex FCA

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 1 2014

The Federal Court of Appeal has again discussed the so-called “promise doctrine” in its October 30, 2014 decision of Apotex Inc. v. Pfizer Canada Inc

CIPO-EPO PPH pilot program set to begin in January 2015

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, European Union
  • -
  • October 31 2014

In another step towards building stronger bilateral relations and fast-tracking the examination of counterpart patent applications, the Canadian

Application for leave to appeal granted - 30 October 2014

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 30 2014

On appeal from the judgment of the Federal Court of Appeal pronounced March 14, 2014. The applicants (collectively, “Sanofi”) are the pat

Personalized medicine: patent issues in Canada and Europe

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, European Union
  • -
  • October 16 2014

Canada Introduction 'Personalized medicine', in its broadest aspects, is essentially the tailoring of treatments to individual characteristics, needs

Dow v NOVA: case summary

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 19 2014

In the Federal Court's decision in The Dow Chemical Company et al v NOVA Chemicals Corporation, 2014 FC 844 ("Dow v NOVA"), in the face of a

Experimental testing in patent actions: federal court issues notice to the profession

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2014

Experimental testing and patent infringement actions often go hand in hand. With respect to providing notice of experimental testing to other parties